Lilly partners with AC Immune for Alzheimer's treatment
U.S. drugmaker Eli Lilly& Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Women Often Wait to Call Help in a Heart Attack
Researchers in Switzerland found that women suffering a heart attack typically waited 37 minutes longer than men before calling an ambulance. (Source: WebMD Health)
Source: WebMD Health - December 11, 2018 Category: Consumer Health News Source Type: news

When Heart Attack Strikes, Women Often Hesitate to Call for Help
TUESDAY, Dec. 11, 2018 -- Women often delay calling for emergency help when heart attack symptoms start, a new study finds. Researchers in Switzerland found that women suffering a heart attack typically waited 37 minutes longer than men before... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2018 Category: General Medicine Source Type: news

Great success for the promotion of young researchers at the University of Bern
(University of Bern) The Swiss National Science Foundation (SNSF) has pledged to finance nine new assistant professorships at the University of Bern within the framework of the first 'Eccellenza' call for proposals. At the same time, an 'Eccellenza' grant was also approved, resulting in a total of approximately 16.2 million in funding flowing to Bern. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 11, 2018 Category: International Medicine & Public Health Source Type: news

ESMO Immuno-Oncology Congress showcases new technologies set to improve cancer treatment
(European Society for Medical Oncology) Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Lonza makes plans for major biomanufacturing plant in China
Swiss CDMO giant Lonza announced Monday that it ’s partnering with GE Healthcare to build a new biomanufacturing facility in China. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 10, 2018 Category: Pharmaceuticals Source Type: news

Statins ARE safe and patients shouldn't stop taking the drugs
Research published last week sparked uproar: Swiss scientists found the benefits only outweigh the risks for people with a very high heart attack risk. But the AHA says: take the study with a pinch of salt. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

Just 4 weeks on an e-bike can dramatically improve your health
(Natural News) Using electronic bikes (e-bikes) is as beneficial as using conventional bicycles in improving cardiorespiratory fitness, according to a study published in the Clinical Journal of Sport Medicine. The study also revealed that even overweight and untrained individuals can benefit from riding an e-bike. Researchers from the University of Basel in Switzerland compared the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
Gilead Sciences Inc. landed former Roche executive Daniel O'Day as its new CEO, and Genentech Inc.'s current CEO will take O'Day's role with Genentech's parent company in a game of musical chairs disclosed Sunday. The job shuffling has implications up and down the employment ranks of the Bay Area's two largest drug makers during critical times for both companies. Gilead (NASDAQ: GILD), based in Foster City, is set up for deeper moves into next-generation cancer drugs while South San Francisco's… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 10, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
Gilead Sciences Inc. landed former Roche executive Daniel O'Day as its new CEO, and Genentech Inc.'s current CEO will take O'Day's role with Genentech's parent company in a game of musical chairs disclosed Sunday. The job shuffling has implications up and down the employment ranks of the Bay Area's two largest drug makers during critical times for both companies. Gilead (NASDAQ: GILD), based in Foster City, is set up for deeper moves into next-generation cancer drugs while South San Francisco's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Sound and vision: how gongs are bringing inner peace to city dwellers
Harmonies in the boom of a gong are transporting busy brains into a meditative stateLeo Cosendai used to be an acutely anxious young man. “I couldn’t cope with taking the train,” he says. “I never felt safe.” So when he moved to London from Switzerland in 2008 to study music, he tried yoga to calm him down. But it was when he discovered gong meditation sessions, otherwise known as sound baths, that he started transforming in to the smiley, serene person he is today. He was so deeply affected by the practice that he ditched his singing and composing career, invested in some gongs of his own and...
Source: Guardian Unlimited Science - December 8, 2018 Category: Science Authors: Amy Fleming Tags: Life and style Psychology Science Health & wellbeing Source Type: news

Roche's lung cancer combo treatment wins FDA approval
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer. (Source: Reuters: Health)
Source: Reuters: Health - December 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can Supervised Heroin Programs Help Opioid Crisis?
To assess the effectiveness of heroin-assisted treatment, the researchers examined evidence from Canada, the Netherlands, Switzerland and the United Kingdom. (Source: WebMD Health)
Source: WebMD Health - December 6, 2018 Category: Consumer Health News Source Type: news

Roche's Tecentriq wins speedy U.S. FDA review for small cell lung cancer
Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has been trailing rivals' revenues. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Assessing India's health with a single question
(Universit é de Gen è ve) A country can estimate its population's health status by using national survey questionnaires. Researchers at UNIGE began wondering whether it was possible to use the question -- 'What would you say about your health status?' - in India, that is used in Europe. They compared Indian and Swiss databases. They found that the question provided a sound understanding of the health status of the Indian population and that the Indian data was more reliable than the Swiss. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Zambia Pilot Demonstrates How to Save Lives, Scale Relief for Children Suffering from Malaria
ByCathy Green Senior technical adviser for community engagement, MAMaZ Against Malaria,Paula Quigley Technical lead, DAI Global HealthDecember 04, 2018The secret: motivated, well-trained community health volunteers.Thousands of infants and children in rural Zambia suffer or die unnecessarily from malaria each year because they lack access to high-quality medicines and proper medical care. But a recent pilot program shows how trained local volunteers administering crucial medicine can keep a child well enough to be transported to a health care facility for further, potentially lifesaving treatment.With technical and finan...
Source: IntraHealth International - December 4, 2018 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Roche says Hemlibra effective in pivotal study
Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Addition of investigational antibody cusatuzumab to robust oncology pipeline reflects Janssen's commitment to advance innovative therapies for blood cancers where unmet medical needs remain UG, Switzerland, December 3, 2018 -- (Healthcare Sales & Market... Biopharmaceuticals, Oncology, Licensing Cilag, argenx BVBA, argenx SE, cusatuzumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 3, 2018 Category: Pharmaceuticals Source Type: news

Novartis SMA treatment could get FDA approval in May
Novartis's gene therapy for spinal muscular atrophy (SMA) could be approved in May 2019 after the U.S. Food and Drug Administration agreed to an accelerated review of the Swiss drugmaker's treatment. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Congo-Kinshasa: Ebola Outbreak is Second Worst in History
[IRC] Geneva, Switzerland -Today (November 29, 2018) the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) reached 426 cases, surpassing the number of cases in the 2000-2001 Uganda outbreak and making it the second worst in history after the 2014 West Africa outbreak which killed over 11,000 people. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 30, 2018 Category: African Health Source Type: news

Ex-Zimmer Biomet SVP loses in court
A former Zimmer Biomet executive has temporarily lost her bid for severance pay and cannot claim company stock options after her 2016 resignation. Robin Barney resigned from her post as a senior vice president claiming a hostile work environment, alleging sex discrimination, breach of contract, and constructive or involuntary discharge. Barney became Zimmer’s SVP of global operations and logistics after serving as an SVP at Biomet since 2008. (The companies merged in 2015.) Barney alleged that Zimmer told her in August 2016 that her position would be moved from Indiana to Switzerland by the end of 2017, requiring her...
Source: Mass Device - November 29, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Legal News Zimmer Biomet Source Type: news

Novartis CEO Vas Narasimhan On The Price Of Gene Therapies:'It's A Challenge We Have To Solve '
In May Novartis announced that it had acquired the gene therapy pioneer AveXis in a $8.7 billion deal, but according to the the Swiss drug giant CEO Vas Narasimhan, he wishes he could have bought the company much earlier. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

Roche Buys U.S. Biotech Jecure in Race for Liver Disease Drugs Roche Buys U.S. Biotech Jecure in Race for Liver Disease Drugs
Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

The virus detectives
(Technical University of Munich (TUM)) Every summer in Southern Germany, Austria and Switzerland, tons of brown trout perish. An interdisciplinary team from the Technical University of Munich (TUM) has now discovered the culprit of the mysterious dying afflicting brown trout. It is triggered by a previously unknown virus, which is related to a virus that infects salmon in the North Atlantic and the Pacific. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 28, 2018 Category: Biology Source Type: news

Roche buys U.S. biotech Jecure in race for liver disease drugs
Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease. (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Alcon to highlight its vision, strategy and benefits as a standalone company to investors and analysts in New York and London
Alcon, the eye care division of Novartis, will today hold its first Capital Markets Day for investors and analysts in relation to the previously-announced intention of Novartis to execute a tax-neutral, 100% spinoff of the Alcon business. If the transaction proceeds, shares in Alcon Inc. will be listed on the SIX Swiss Exchange (SIX) and the New York Stock Exchange (NYSE) under the ticker symbol "ALC". (Source: World Pharma News)
Source: World Pharma News - November 27, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Quadriplegic Mayo scientist helps advance spine injury tech
A team of researchers at Minnesota’s Mayo clinic, led by an individual who was left with quadriplegia from a teenage injury, are pushing the boundaries of spinal regeneration, according to a new Star Tribune report. The group, led by spinal cord injury researcher Peter Grahn, has published findings from a study that suggests that electrical stimulation, over time, can help restore movement to paralyzed limbs. Results from the study was published in the journal Natural Medicine, according to the report. The researchers initially set out to replicate a similar study that showed that electrical stimulation could help in...
Source: Mass Device - November 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Featured Spinal Mayo Clinic Source Type: news

Better statistics for better health for pregnant women and babies in Europe in 2015
(INSERM (Institut national de la sant é et de la recherche m é dicale)) The Euro-Peristat network is pleased to announce the publication of a new European Perinatal Health Report, 'Core indicators of the health and care of pregnant women and babies in Europe in 2015'.This new report is based on data covering over five million births in the year 2015 compiled from public national satistical systems in the EU member states and Iceland, Norway and Switzerland. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 26, 2018 Category: International Medicine & Public Health Source Type: news

Free and based on need? Not for everyone
One thing we like to boast of about the NHS is that health care is free – “at the point of delivery” – and based on patients’ clinical need, not their ability to pay. But that is no longer true for everyone. The NHS Constitution now says that “NHS services are free of charge, except in limited circumstances sanctioned by Parliament”. Those ‘limited circumstances’ include an “immigration health surcharge” for people from outside Europe coming to live and work in the UK on a temporary visa. From December, this will mean paying £400 per person, for e...
Source: UNISON Health care news - November 22, 2018 Category: UK Health Authors: Val Johnston Tags: Blogs News campaign health health care health charges NHS Source Type: news

'I was devastated by my husband's assisted death'
Deborah Binner respected her husband's decision to die at a Swiss clinic but says it felt like abandonment. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 22, 2018 Category: Consumer Health News Source Type: news

Assisted suicide: 'I was devastated by my husband's assisted death'
Deborah Binner respected her husband's decision to die at a Swiss clinic but says it felt like abandonment. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 22, 2018 Category: Consumer Health News Source Type: news

FDA Approves Gamifant(R) (emapalumab), the First and Only Treatment for Primary Haemophagocytic Lymphohistiocytosis (HLH)
STOCKHOLM, Nov 20, 2018 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI), an international biopharmaceutical company dedicated to rare diseases, and Novimmune SA, a Swiss biotech company, today announce t... Biopharmaceuticals, FDA Swedish Orphan Biovitrum, Gamifant, emapalumab, Lymphohistiocytosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2018 Category: Pharmaceuticals Source Type: news

Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team
LAUSANNE, Switzerland, November 20, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments for acute and chronic back- and front-of-the-eye diseases, an... Biopharmaceuticals, Ophthalmology, Personnel Oculis, OC-118, solubilizing nanoparticle (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2018 Category: Pharmaceuticals Source Type: news

Verily and Novartis Halt Glucose Detection Lens Work
When Alphabet’s Verily Lifesciences plunged into medtech the company took a deep dive. Some collaborations seemed futuristic and others were just natural. However, not all of the collaborations were going to be successful. And so, Verily, the former life sciences division of Google, along with Alcon, Novartis’ eyecare division, are putting the brakes on a plan for its smart lens to detect glucose levels. Brian Otis, PHD, Chief Technical Officer for Verily announced the news in a recent blog posting. “Our clinical work on the glucose-sensing lens demonstrated that there ...
Source: MDDI - November 19, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Digital Health Manager
Location: Switzerland, Basel Job Type: Full-Time Employer: Roche As a Digital Health Leader you will be part of the Healthcare Solutions team in the PDMA organization working in close collaboration with the medical network as well as key strategic partners in the Roche Pharma organization. In this role you will: (Source: eHealth News EU)
Source: eHealth News EU - November 19, 2018 Category: Information Technology Tags: Featured Jobs Source Type: news

E-Commerce Giants Under Fire for Retailing Hazardous Mercury-Based Cosmetics
By Thalif DeenNEW YORK, Nov 16 2018 (IPS)A coalition of over 50 civil society organizations (CSOs), from more than 20 countries, have urged two of the world’s largest multi-billion dollar E-commerce retailers – Amazon and eBay – to stop marketing “dangerous and illegal mercury-based skin lightening creams.” The protest is part of a coordinated global campaign against a growing health hazard in the field of cosmetics.So far, the groups have reached out to the US Food & Drug Administration (FDA), the United Nations, the World Health Organization (WHO) and INTERPOL, the Lyon-based internation...
Source: IPS Inter Press Service - Health - November 16, 2018 Category: International Medicine & Public Health Authors: Thalif Deen Tags: Editors' Choice Environment Featured Global Global Governance Headlines Health IPS UN: Inside the Glasshouse Mercury Population Poverty & SDGs TerraViva United Nations Source Type: news

Central Asian and Eastern European Surveillance of Antimicrobial Resistance: Annual Report 2017
Source: World Health Organization, Regional Office for Europe. Published: 6/2018. This 143-page report describes antimicrobial resistance (AMR) data gathered through the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) network from nine countries in the World Health Organization European Region – Belarus, Bosnia and Herzegovina, Georgia, Montenegro, the Russian Federation, Serbia, Switzerland, the former Yugoslav Republic of Macedonia, and Turkey – and Kosovo. The aim of the report is to provide guidance and inspiration to countries that are building or strengthening their n...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 16, 2018 Category: International Medicine & Public Health Source Type: news

Roche's Tecentriq Wins Fast FDA Review in Tough-to-Treat Breast Cancer Roche's Tecentriq Wins Fast FDA Review in Tough-to-Treat Breast Cancer
Swiss drugmaker Roche said on Tuesday its Tecentriq medicine will get a speedy review by U.S. regulators in a tough-to-treat form of breast cancer, as it seeks to be the first company to have its immunotherapy win approval in this indication.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Novartis launches third-to-market Remicade copy in Germany
Novartis launched a copy of Johnson& Johnson's (J&J) inflammation-fighting Remicade in Germany on Thursday as the Swiss drugmaker aims to catch rival biosimilars that are already available in Europe's largest healthcare market. (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cerus Endovascular starts European trial of intracranial aneurysm device
Cerus Endovascular said it has enrolled the first patients in a study designed to assess the safety of the company’s Contour neurovascular system, which is designed to reduce the risk of rupture when treating patients with intracranial aneurysms. Intracranial aneurysms occur at the rate of nine per 100,000 with a wide range; in some countries, the rate is up to 20 per 100,000, according to Karger Publishers in Basel, Switzerland, a medical and scientific publishing company. Get the full story on our sister site, Medical Design & Outsourcing. The post Cerus Endovascular starts European trial of intr...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Neurological Research & Development Vascular cerusendovascular Source Type: news

Novartis 'completely committed' to Sandoz, has no split-off plan
Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a newspaper reported Chief Executive Vas Narasimhan planned to split the unit off. (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Are Smoothies Healthy? Here ’s What the Experts Say
Smoothies have a health glow about them. They’re often an integral part of cleanses, and they’re ubiquitous at health food stores and health-centric restaurants. And the smoothie trend is still going strong. Workout studios serve them up post-class, dietitians preach their powers and fit celebrities tout their nutritional prowess. But are smoothies healthy? Here’s what you should know about the drink, whether you’re picking one up or making your own. How to make healthy smoothies You can put nearly anything into a smoothie. But most consist of liquid (like water, non-dairy milk or kefir), fruits, ve...
Source: TIME: Health - November 14, 2018 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Diet/Nutrition Source Type: news

GenePlanet Presents its Innovative Health Platform at MEDICA 2018
GenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldorf, Germany, from 12-15 November. "Our participation at MEDICA represents a great opportunity to introduce our solutions to a highly-qualified audience. (Source: eHealth News EU)
Source: eHealth News EU - November 14, 2018 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Advanced computer technology & software turn species identification interactive
(Pensoft Publishers) Representing a group of successful biocontrol agents for various pest fruit flies, a parasitic wasp genus remains overlooked, with its most recent identification key dating back to 1969, even though many new species have been added since then. Through a recent study, published in the open access Biodiversity Data Journal, which also describes one new to science species, Swiss scientists demonstrate the advantages of new-age interactive identification keys, produced with specialised, free-to-use software. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Roche's Tecentriq wins fast FDA review in tough-to-treat breast cancer
Roche's Tecentriq medicine will get a speedy review by U.S. regulators in a tough-to-treat form of breast cancer as the Swiss drugmaker seeks to be the first company to have its immunotherapy win approval in this indication. (Source: Reuters: Health)
Source: Reuters: Health - November 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cocaine Cut With Anti-Worming Drug, Levamisole, May Cause Brain Damage
THURSDAY, Nov. 8, 2018 -- Cocaine is often cut with the anti-worming drug levamisole -- and the combination is linked to brain damage, Swiss researchers report. " We can assume from our findings that it is not just cocaine that changes the brain,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 8, 2018 Category: General Medicine Source Type: news

Explaining socially motivated travel with social network analysis: survey method and results from a study in Zurich, Switzerland - Guidon S, Wicki M, Bernauer T, Axhausen KW.
It has been hypothesized that a crucial factor to understand and explain socially motivated leisure travel is understanding the spatial distribution of individuals' contacts. Still, only little is known about their actual link. Egocentric social network an... (Source: SafetyLit)
Source: SafetyLit - November 7, 2018 Category: International Medicine & Public Health Tags: Pedestrians and Bicycles Source Type: news

Report: Medacta readies for Swiss IPO
Swiss medtech company Medacta is preparing for an initial public offering on the SIX Swiss Exchange for next spring, according to a Reuters report. The deal is being led by Credit Suisse and Morgan Stanley and joined by JP Morgan and UBS, three people familiar with the matter told Reuters. Neither the company or the banks indicated in the deal have commented on the matter, according to the report. Medacta pulls in annual sales of approximately $300 million, and is likely to float a minority stake initially, Reuters reports. The company employs around 930 people and develops orthopedic devices for the knee and spinal market...
Source: Mass Device - November 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Initial Public Offering (IPO) Orthopedics Medacta Source Type: news

Great honor for research on vehicle emissions
(Swiss Federal Laboratories for Materials Science and Technology (EMPA)) This year's Swiss Aerosol Award goes to Maria Mu ñ oz. The Empa researcher investigated the emission behavior of so-called GDI engines (gasoline-direct injection). Her results are alarming: GDI vehicles emit up to 17 times more carcinogenic substances than modern diesel vehicles. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 5, 2018 Category: Biology Source Type: news

First discovery of adventive populations of Trissolcus japonicus
(Springer) MSc Judith Stahl and Dr Tim Haye led an international team of researchers, including those from the University of Torino and the USDA Agricultural Research Service, who used DNA analysis to confirm the wasp - which is native to China,Japans and Korea - was found in Switzerland in 2017. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 2, 2018 Category: Biology Source Type: news